Market Closed -
Nyse
04:00:01 2024-05-17 pm EDT
|
5-day change
|
1st Jan Change
|
46.06
USD
|
+0.88%
|
|
+1.28%
|
+10.80%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,830
|
3,685
|
5,119
|
3,070
|
3,790
|
4,203
|
-
|
-
|
Enterprise Value (EV)
1 |
3,194
|
4,908
|
6,377
|
4,608
|
5,324
|
5,741
|
5,480
|
5,286
|
P/E ratio
|
4.85
x
|
27.8
x
|
22.3
x
|
4.42
x
|
50.1
x
|
26.3
x
|
23.6
x
|
-
|
Yield
|
2.14%
|
2.04%
|
1.56%
|
2.84%
|
2.41%
|
2.25%
|
2.4%
|
2.52%
|
Capitalization / Revenue
|
0.99
x
|
1.14
x
|
1.06
x
|
0.9
x
|
1.21
x
|
1.31
x
|
1.24
x
|
1.17
x
|
EV / Revenue
|
1.12
x
|
1.51
x
|
1.32
x
|
1.36
x
|
1.69
x
|
1.78
x
|
1.62
x
|
1.47
x
|
EV / EBITDA
|
10.1
x
|
13.1
x
|
11
x
|
7.79
x
|
10.6
x
|
10.8
x
|
9.44
x
|
8.33
x
|
EV / FCF
|
14.5
x
|
31.1
x
|
47.9
x
|
15.7
x
|
64.8
x
|
47.3
x
|
27.6
x
|
-
|
FCF Yield
|
6.89%
|
3.22%
|
2.09%
|
6.36%
|
1.54%
|
2.12%
|
3.62%
|
-
|
Price to Book
|
2.72
x
|
2.17
x
|
2.89
x
|
1.33
x
|
-
|
1.76
x
|
1.67
x
|
1.54
x
|
Nbr of stocks (in thousands)
|
76,915
|
91,476
|
91,491
|
90,944
|
91,161
|
91,255
|
-
|
-
|
Reference price
2 |
36.79
|
40.28
|
55.95
|
33.76
|
41.57
|
46.06
|
46.06
|
46.06
|
Announcement Date
|
1/28/20
|
2/9/21
|
2/8/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,863
|
3,242
|
4,819
|
3,397
|
3,143
|
3,219
|
3,392
|
3,587
|
EBITDA
1 |
316
|
374.8
|
581.2
|
591.7
|
501.8
|
529.9
|
580.4
|
634.6
|
EBIT
1 |
228.5
|
263
|
429
|
352
|
312.8
|
344.2
|
393.9
|
453.7
|
Operating Margin
|
7.98%
|
8.11%
|
8.9%
|
10.36%
|
9.95%
|
10.69%
|
11.61%
|
12.65%
|
Earnings before Tax (EBT)
1 |
109.4
|
139
|
304.6
|
63.8
|
87.3
|
212.8
|
236.8
|
-
|
Net income
1 |
588.6
|
131.6
|
230.8
|
703.1
|
75.7
|
160.9
|
179.4
|
-
|
Net margin
|
20.56%
|
4.06%
|
4.79%
|
20.7%
|
2.41%
|
5%
|
5.29%
|
-
|
EPS
2 |
7.580
|
1.450
|
2.510
|
7.630
|
0.8300
|
1.750
|
1.950
|
-
|
Free Cash Flow
1 |
220
|
157.9
|
133.2
|
292.9
|
82.2
|
121.5
|
198.6
|
-
|
FCF margin
|
7.69%
|
4.87%
|
2.76%
|
8.62%
|
2.62%
|
3.77%
|
5.86%
|
-
|
FCF Conversion (EBITDA)
|
69.62%
|
42.13%
|
22.92%
|
49.5%
|
16.38%
|
22.93%
|
34.23%
|
-
|
FCF Conversion (Net income)
|
37.38%
|
119.98%
|
57.71%
|
41.66%
|
108.59%
|
75.53%
|
110.72%
|
-
|
Dividend per Share
2 |
0.7880
|
0.8200
|
0.8750
|
0.9600
|
1.000
|
1.037
|
1.104
|
1.160
|
Announcement Date
|
1/28/20
|
2/9/21
|
2/8/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,202
|
1,294
|
1,302
|
823.3
|
790.4
|
845.7
|
824.4
|
753.7
|
719
|
829
|
833.5
|
798.9
|
760.4
|
885.7
|
881.4
|
EBITDA
1 |
125.8
|
171.4
|
169.7
|
119.3
|
190.8
|
133.8
|
131.3
|
122.7
|
113.9
|
143.1
|
137.1
|
129.3
|
119.8
|
153.8
|
153.6
|
EBIT
1 |
85.2
|
136.4
|
133.8
|
80.8
|
60.3
|
84.2
|
84.1
|
75.3
|
69.2
|
100.2
|
92.5
|
82.68
|
73.73
|
-
|
-
|
Operating Margin
|
7.09%
|
10.54%
|
10.27%
|
9.81%
|
7.63%
|
9.96%
|
10.2%
|
9.99%
|
9.62%
|
12.09%
|
11.1%
|
10.35%
|
9.7%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
51.1
|
111.1
|
114.7
|
-29
|
-77.4
|
29
|
32.7
|
5
|
20.6
|
66.5
|
56.4
|
46.2
|
35.7
|
59.5
|
64.8
|
Net income
1 |
29.8
|
84.2
|
84.7
|
-10.3
|
544.5
|
19.9
|
22.1
|
5.1
|
28.6
|
49.4
|
43.25
|
35.1
|
27.1
|
45.2
|
49.3
|
Net margin
|
2.48%
|
6.51%
|
6.5%
|
-1.25%
|
68.89%
|
2.35%
|
2.68%
|
0.68%
|
3.98%
|
5.96%
|
5.19%
|
4.39%
|
3.56%
|
5.1%
|
5.59%
|
EPS
2 |
0.3200
|
0.9100
|
0.9200
|
-0.1100
|
5.980
|
0.2200
|
0.2400
|
0.0600
|
0.3100
|
0.5400
|
0.4700
|
0.3850
|
0.2950
|
0.5000
|
0.5400
|
Dividend per Share
2 |
0.2375
|
0.2375
|
0.2375
|
0.2375
|
0.2475
|
0.2475
|
0.2475
|
0.2475
|
0.2575
|
0.2575
|
0.2590
|
0.2590
|
0.2590
|
-
|
-
|
Announcement Date
|
2/8/22
|
4/20/22
|
7/26/22
|
11/2/22
|
2/15/23
|
5/3/23
|
7/27/23
|
11/2/23
|
2/14/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
365
|
1,223
|
1,258
|
1,538
|
1,534
|
1,538
|
1,276
|
1,083
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
1.154
x
|
3.263
x
|
2.164
x
|
2.599
x
|
3.057
x
|
2.903
x
|
2.199
x
|
1.707
x
|
Free Cash Flow
1 |
220
|
158
|
133
|
293
|
82.2
|
122
|
199
|
-
|
ROE (net income / shareholders' equity)
|
-
|
11.5%
|
13.3%
|
12.1%
|
9.3%
|
8.79%
|
9.83%
|
9.91%
|
ROA (Net income/ Total Assets)
|
-
|
3.85%
|
4.68%
|
4.48%
|
3.6%
|
4%
|
4.3%
|
-
|
Assets
1 |
-
|
3,418
|
4,934
|
15,710
|
2,103
|
4,022
|
4,172
|
-
|
Book Value Per Share
2 |
13.50
|
18.60
|
19.40
|
25.30
|
-
|
26.10
|
27.60
|
30.00
|
Cash Flow per Share
2 |
-
|
-
|
-
|
4.320
|
2.200
|
3.910
|
4.340
|
4.790
|
Capex
1 |
81.7
|
63.7
|
101
|
106
|
119
|
139
|
135
|
140
|
Capex / Sales
|
2.85%
|
1.96%
|
2.09%
|
3.11%
|
3.8%
|
4.31%
|
3.97%
|
3.9%
|
Announcement Date
|
1/28/20
|
2/9/21
|
2/8/22
|
2/15/23
|
2/14/24
|
-
|
-
|
-
|
Last Close Price
46.06
USD Average target price
52
USD Spread / Average Target +12.90% Consensus |
1st Jan change
|
Capi.
|
---|
| +10.80% | 4.2B | | +17.80% | 66.73B | | +2.92% | 49.79B | | +19.98% | 42.5B | | +22.29% | 26.45B | | +12.04% | 19.66B | | +1.27% | 17.18B | | -22.98% | 15.82B | | +2.97% | 15.56B | | -9.25% | 15.41B |
Other Specialty Chemicals
|